Chiron / nal von minden - London NPS 2018

New Psychoactive Substances | Trondheim 2014

Monitoring Trends, Tackling Challenges

On the 27th May 2014 Chiron hosted a one day seminar on New Psychoactive Substances (NPS) at the Clarion Hotel and Congress, in our home town of Trondheim, Norway. The day was a huge success attracting up to 70 delegates, from countries including Norway, Sweden, Denmark, UK, Germany and Poland. The day provided a perfect opportunity for scientists, clinicians, law enforcement, customs officials, and others working in this challenging area, to come together and share knowledge and experiences. New psychoactive substances (NPS) (designer drugs, “legal highs”) – legal imitations of controlled drugs - have been emerging onto the recreational drug scene at an unprecedented rate, and early warning initiatives, such as those discussed, are vital in keeping pace with ingenuity of the market, and the speed at which it reacts. With the permission of our invited speakers, we are delighted to share with you the proceedings of the day.


Synthesis and purification of Reference Materials for NPS
Huiling Liu, Chiron AS (Trondheim, Norway)

Monitoring new psychoactive substances - The UK experience and beyond
John Corkery, Hertfordshire University (Hertfordshire, UK)

Spotlight on AH-7921
Matthew Connolly, Chiron AS (Trondheim, Norway)

Overview of drug seizures at the Norwegian boarder
Jarle Trandum, Norwegian Customs & Excise

Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project
Anders Helander, Karolinska Institute (Stockholm, Sweden) [Presentation to follow]

Findings of new psychoactive drugs in forensic samples
Elisabeth Leere Øiestad, Norwegian Institute of Public Health (Oslo, Norway)

Spotlight on designer benzodiazepines
Jenny Button, Chiron (UK) Limited (London, UK)

Development and application of methodology for designer drugs
Solfrid Hegstad & Wenche Rödseth, St Olavs Hospital (Trondheim, Norway)

Eurostars Quantum Spice Project - Rapid tests for Synthetic Cannabinoids
Torsten Winkler, nal von minden GmbH (Regensburg, Germany)

Using biomarkers in wastewater to monitor community drug use: A conceptual approach for dealing with new psychoactive substances
Malcolm J. Reid, Norwegian Institute for Water Research - NIVA (Oslo, Norway)

13C-labeled internal standards for LC-MS/MS analysis
Huiling Liu, Chiron AS (Trondheim, Norway)

Stability of emerging new psychoactive substances
Simon Elliot, ROAR Forensics Ltd (Malvern, UK)